What is it about?

This article describes the views and expectations of all stakeholders about marketing authorization for new drugs

Featured Image

Read the Original

This page is a summary of: Marketing Authorization Procedures for Advanced Cancer Drugs, Medical Decision Making, February 2017, SAGE Publications,
DOI: 10.1177/0272989x17691953.
You can read the full text:

Read

Contributors

The following have contributed to this page